Clinical Research Unit
Operation Manager: Aliza Eckerstein
Medical Manager: Prof. Talia Golan: Phase 1,
Dr. Tal Sela: Advanced Phases
Ethics and Safety Committee Submission Manager: Sigal Gertz
Contracts, Budget and Control Manager:
Sigal Tamir
Pharmacist: Lt. Col. Anat Amitai
Nursing Director of Hemato-Oncology and General First Phase Clinical Studies: Hala Litvin
Administrative Manager: Diana Broditziano
First Phase Operation Manager: Ilanit Radinski
Pathology Operation Manager: Julia Kalnov
Data Management Manager: Katia Vargov
Translation Laboratory Manager:
Sharon Halperin
Lung Cultivation Research Manager: Kate Milov
Urinary System Cultivation Research Manager: Natasha Bardi
Digestive System and Gynecology Cultivation Research Manager: Anna Rappoport
Breast and Head-Neck Research Manager: Vardina Dagan
Contact:
Phone: 03-5304964, 03-5304364, 03-5307041
Fax: 03-5304518, 03-5304498
In recent years, there has been significant progress in understanding the biology and mechanisms of cancer development and progression. This has led to pharmaceutical companies entering the field of oncology and creating "smart" drugs that target these mechanisms. Currently, there are almost 1,000 new drugs in the pipelines of pharmaceutical companies, undergoing various stages of clinical trials in cancer patients.
A clinical trial in humans is conducted to assess the effectiveness and safety of a specific medical treatment, such as a drug, medical device, radiation, or other therapy. Conducting clinical trials is crucial for developing new treatments and bringing them to fruition.
Health authorities and ethics committees at the Sheba Medical Center oversee clinical trials to ensure the rights, safety, and well-being of all participants. Written consent from the patient is required to participate in a clinical trial, and patients have the right to withdraw consent at any stage of the treatment.
If any important new findings regarding the effectiveness and safety of the investigational drug arise during the trial, which may impact continued participation, the treating physician will be informed. In such cases, an updated consent form may be necessary.
Participating in a clinical trial may include compensation for travel expenses. The research coordinator will coordinate the amount and method of reimbursement. No additional payments are provided apart from travel reimbursement. Patients are not required to make any payments to participate in a clinical trial.
